Butterfly Medical

Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH)

placeYokneam Illit, Northern District, Israel calendar_todayFounded 2014 groups9 employees language butterfly-medical.com

Innovation

8 patent families (5 granted) — focus: Human necessities; filing pace steady. Cited 207 times.

YearFilings
20151
20161
20172
20181
20194
20203
20213
20222
20234
20246
20253
20261

Social engagement

Social engagement: 2.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include New Rhein, Array, Array; 1 has since exited.

Investor typeCountShare
Venture capital215%
Private equity18%
Angel & family office18%
Accelerator & incubator323%
Other / undisclosed646%

Recent activity

28 May 2026
Event
American Urological Association Annual Meeting AUA26
12 May 2026
Event
AUA26
Coming soon